If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> ARCHIVE<br /> Volume 109 Number 1 JANuArY 2014<br /> www.amjgastro.com<br /> official publication of the american college of gastroenterology<br /> leading articles of the month<br /> Clinical and Systematic Reviews<br /> 23 The Role of Thiopurines in Reducing the Need for Surgical<br /> Resection in Crohn’s Disease: A Systematic Review<br /> and Meta-Analysis CME<br /> S. Chatu, V. Subramanian, S. Saxena and R.C.G. Pollok<br /> Esophagus<br /> 52 Objective Manometric Criteria for the Rumination Syndrome<br /> B.F. Kessing, A.J. Bredenoord and A.J.P.M. Smout<br /> Stomach<br /> 60 Effect of Helicobacter pylori Eradication on Metachronous<br /> Recurrence After Endoscopic Resection of Gastric Neoplasm<br /> S.E. Bae, H.-Y. Jung, J. Kang, Y.S. Park, S. Baek, J.-H. Jung, J.Y. Choi,<br /> M.-Y. Kim, J.Y. Ahn, K.-S. Choi, D.H. Kim, J.H. Lee, K.D. Cho<a title="AJG_Vol.109.No.9 page 1" href="http://viewer.zmags.com/publication/e98596ea?page=1"> ARCHIVE Volume 109 Number 1 JANuArY 2014 www.amj</a> <a title="AJG_Vol.109.No.9 page 2" href="http://viewer.zmags.com/publication/e98596ea?page=2"> VOLUME 109 NUMBER 9 SEPTEMBER 2014 www.amjgastro.</a> <a title="AJG_Vol.109.No.9 page 3" href="http://viewer.zmags.com/publication/e98596ea?page=3"> Superior cleansing* *Demonstrated</a> <a title="AJG_Vol.109.No.9 page 4" href="http://viewer.zmags.com/publication/e98596ea?page=4"> Lowest volume of active prep solution— only 10 oz</a> <a title="AJG_Vol.109.No.9 page 5" href="http://viewer.zmags.com/publication/e98596ea?page=5"> The following is a brief summary only; see full P</a> <a title="AJG_Vol.109.No.9 page 6" href="http://viewer.zmags.com/publication/e98596ea?page=6"> www.amjgastro.com The American Journal of</a> <a title="AJG_Vol.109.No.9 page 7" href="http://viewer.zmags.com/publication/e98596ea?page=7"> Exciting news for the IBD community INTRODUCING C</a> <a title="AJG_Vol.109.No.9 page 8" href="http://viewer.zmags.com/publication/e98596ea?page=8"> CCFA Perspectives: IBD Review for Professionals ·</a> <a title="AJG_Vol.109.No.9 page 9" href="http://viewer.zmags.com/publication/e98596ea?page=9"> References: 1. Li K, Foy E, Ferreon JC, et al. Im</a> <a title="AJG_Vol.109.No.9 page 10" href="http://viewer.zmags.com/publication/e98596ea?page=10"> HCV: Master of Elusion The human body does everyt</a> <a title="AJG_Vol.109.No.9 page 11" href="http://viewer.zmags.com/publication/e98596ea?page=11"> Save the Date! October 17–22, 2014 ACG2014 </a> <a title="AJG_Vol.109.No.9 page 12" href="http://viewer.zmags.com/publication/e98596ea?page=12"> NOT ALL PREPS ARE CREATED EQUAL. MoviPrep® vs Su</a> <a title="AJG_Vol.109.No.9 page 13" href="http://viewer.zmags.com/publication/e98596ea?page=13"> MOVIPREP® (PEG-3350, sodium sulfate, sodium chlor</a> <a title="AJG_Vol.109.No.9 page 14" href="http://viewer.zmags.com/publication/e98596ea?page=14"> Leave questions in the past. Get answers as to wh</a> <a title="AJG_Vol.109.No.9 page 15" href="http://viewer.zmags.com/publication/e98596ea?page=15"> For patients with active, mild to moderate ulcera</a> <a title="AJG_Vol.109.No.9 page 16" href="http://viewer.zmags.com/publication/e98596ea?page=16"> To request samples and get real-time answers on p</a> <a title="AJG_Vol.109.No.9 page 17" href="http://viewer.zmags.com/publication/e98596ea?page=17"> BRIEF SUMMARY: Consult the Full Prescribing Infor</a> <a title="AJG_Vol.109.No.9 page 18" href="http://viewer.zmags.com/publication/e98596ea?page=18"> not always possible to reliably estimate their fr</a> <a title="AJG_Vol.109.No.9 page 19" href="http://viewer.zmags.com/publication/e98596ea?page=19"> INDICATION SOVALDI is a hepatitis C virus (HCV) n</a> <a title="AJG_Vol.109.No.9 page 20" href="http://viewer.zmags.com/publication/e98596ea?page=20"> SOVALDI REGIMENS WERE STUDIED ACROSS MANY TYPES O</a> <a title="AJG_Vol.109.No.9 page 21" href="http://viewer.zmags.com/publication/e98596ea?page=21"> ADDITIONAL SUBJECTS STUDIED WITH SOVALDI REGIMENS</a> <a title="AJG_Vol.109.No.9 page 22" href="http://viewer.zmags.com/publication/e98596ea?page=22"> SOVALDI® (sofosbuvir) Brief summary of full Pre</a> <a title="AJG_Vol.109.No.9 page 23" href="http://viewer.zmags.com/publication/e98596ea?page=23"> Brief Summary (cont.) Table 2 Percentage of Subj</a> <a title="AJG_Vol.109.No.9 page 24" href="http://viewer.zmags.com/publication/e98596ea?page=24"> BRIEF SUMMARY UCERIS (budesonide) extended releas</a> <a title="AJG_Vol.109.No.9 page 25" href="http://viewer.zmags.com/publication/e98596ea?page=25"> InActive,MildtoModerateUlcerativeColitis(UC) POWE</a> <a title="AJG_Vol.109.No.9 page 26" href="http://viewer.zmags.com/publication/e98596ea?page=26"> official publication of the american college</a> <a title="AJG_Vol.109.No.9 page 27" href="http://viewer.zmags.com/publication/e98596ea?page=27"> GI�QUALITY�IMPROVEMENT�CONSORTIUM��LTD� 3 Se�ing</a> <a title="AJG_Vol.109.No.9 page 28" href="http://viewer.zmags.com/publication/e98596ea?page=28"> INNOVATIVE CLINICAL RESEARCH OPEN ACCESS CAS</a> <a title="AJG_Vol.109.No.9 page 29" href="http://viewer.zmags.com/publication/e98596ea?page=29"> IMPORTANT SAFETY INFORMATION SERIOUS INFECTIONS P</a> <a title="AJG_Vol.109.No.9 page 30" href="http://viewer.zmags.com/publication/e98596ea?page=30"> GET SERIOUS WITH REMICADE® (infIiximab) He may b</a> <a title="AJG_Vol.109.No.9 page 31" href="http://viewer.zmags.com/publication/e98596ea?page=31"> IMPORTANT SAFETY INFORMATION (CONTINUED) MALIGNAN</a> <a title="AJG_Vol.109.No.9 page 32" href="http://viewer.zmags.com/publication/e98596ea?page=32"> REMICADE (infliximab) Lyophilized Concentrate for</a> <a title="AJG_Vol.109.No.9 page 33" href="http://viewer.zmags.com/publication/e98596ea?page=33"> REMICADE® (infliximab) disease, psoriatic arthr</a> <a title="AJG_Vol.109.No.9 page 34" href="http://viewer.zmags.com/publication/e98596ea?page=34"> REMICADE® (infliximab) REMICADE infusions, 3% w</a> <a title="AJG_Vol.109.No.9 page 35" href="http://viewer.zmags.com/publication/e98596ea?page=35"> REMICADE® (infliximab) Adverse Reactions in Pso</a> <a title="AJG_Vol.109.No.9 page 36" href="http://viewer.zmags.com/publication/e98596ea?page=36"> REMICADE® (infliximab) REMICADE during or withi</a> <a title="AJG_Vol.109.No.9 page 37" href="http://viewer.zmags.com/publication/e98596ea?page=37"> RetroView ™ GivesYouThe Power To See It. One loo</a> <a title="AJG_Vol.109.No.9 page 38" href="http://viewer.zmags.com/publication/e98596ea?page=38"> Clinical appearance and histopathological feature</a> <a title="AJG_Vol.109.No.9 page 39" href="http://viewer.zmags.com/publication/e98596ea?page=39"> CONTENTS 1.0 0.8 0.6 Observed risk 0</a> <a title="AJG_Vol.109.No.9 page 40" href="http://viewer.zmags.com/publication/e98596ea?page=40"> www.amjgastro.com </a> <a title="AJG_Vol.109.No.9 page 41" href="http://viewer.zmags.com/publication/e98596ea?page=41"> Recruiting the best researchers and medical profe</a> <a title="AJG_Vol.109.No.9 page 42" href="http://viewer.zmags.com/publication/e98596ea?page=42"> The following is a brief summary only. See comple</a> <a title="AJG_Vol.109.No.9 page 43" href="http://viewer.zmags.com/publication/e98596ea?page=43"> MAKE THE MOVE APRISO SAVINGS PROGRAM $0 $10</a> <a title="AJG_Vol.109.No.9 page 44" href="http://viewer.zmags.com/publication/e98596ea?page=44"> nature publishing group </a> <a title="AJG_Vol.109.No.9 page 45" href="http://viewer.zmags.com/publication/e98596ea?page=45"> 1302 THE RED SECTION What’s Hot in the RED J</a> <a title="AJG_Vol.109.No.9 page 46" href="http://viewer.zmags.com/publication/e98596ea?page=46"> THE RED SECTION 1303 What’s Hot in the RED J</a> <a title="AJG_Vol.109.No.9 page 47" href="http://viewer.zmags.com/publication/e98596ea?page=47"> 1304 THE RED SECTION </a> <a title="AJG_Vol.109.No.9 page 48" href="http://viewer.zmags.com/publication/e98596ea?page=48"> is generally accepted that adherence is better wi</a> <a title="AJG_Vol.109.No.9 page 49" href="http://viewer.zmags.com/publication/e98596ea?page=49"> 1306 THE RED SECTION </a> <a title="AJG_Vol.109.No.9 page 50" href="http://viewer.zmags.com/publication/e98596ea?page=50"> THE RED SECTION 1307 Table 2. Celiac patient</a> <a title="AJG_Vol.109.No.9 page 51" href="http://viewer.zmags.com/publication/e98596ea?page=51"> Similarly, participants with CD rated overall</a> <a title="AJG_Vol.109.No.9 page 52" href="http://viewer.zmags.com/publication/e98596ea?page=52"> THE RED SECTION 1309 Table 4. Celiac patient</a> <a title="AJG_Vol.109.No.9 page 53" href="http://viewer.zmags.com/publication/e98596ea?page=53"> 1310 THE RED SECTION common and well-valid</a> <a title="AJG_Vol.109.No.9 page 54" href="http://viewer.zmags.com/publication/e98596ea?page=54"> 42. Wilcox AR, Dragnev MC, Darcey CJ et al. A new</a> <a title="AJG_Vol.109.No.9 page 55" href="http://viewer.zmags.com/publication/e98596ea?page=55"> 1312 THE RED SECTION </a> <a title="AJG_Vol.109.No.9 page 56" href="http://viewer.zmags.com/publication/e98596ea?page=56"> THE RED SECTION 1313 with specialists in com</a> <a title="AJG_Vol.109.No.9 page 57" href="http://viewer.zmags.com/publication/e98596ea?page=57"> Paris Is 30-40 mm Left Colon Adenoma 73 Y Male - </a> <a title="AJG_Vol.109.No.9 page 58" href="http://viewer.zmags.com/publication/e98596ea?page=58"> THE RED SECTION 1315 Table 2. Physician asse</a> <a title="AJG_Vol.109.No.9 page 59" href="http://viewer.zmags.com/publication/e98596ea?page=59"> 1316 THE RED SECTION </a> <a title="AJG_Vol.109.No.9 page 60" href="http://viewer.zmags.com/publication/e98596ea?page=60"> REFERENCES 1. Cancer Facts & Figures 2013. Ameri</a> <a title="AJG_Vol.109.No.9 page 61" href="http://viewer.zmags.com/publication/e98596ea?page=61"> 1318 THE RED SECTION Case #1: 74-</a> <a title="AJG_Vol.109.No.9 page 62" href="http://viewer.zmags.com/publication/e98596ea?page=62"> THE RED SECTION 1319 Re</a> <a title="AJG_Vol.109.No.9 page 63" href="http://viewer.zmags.com/publication/e98596ea?page=63"> 1320 THE RED SECTION Ne</a> <a title="AJG_Vol.109.No.9 page 64" href="http://viewer.zmags.com/publication/e98596ea?page=64"> THE RED SECTION 1321 Agree </a> <a title="AJG_Vol.109.No.9 page 65" href="http://viewer.zmags.com/publication/e98596ea?page=65"> 1322 THE RED SECTION </a> <a title="AJG_Vol.109.No.9 page 66" href="http://viewer.zmags.com/publication/e98596ea?page=66"> THE RED SECTION 1323 No</a> <a title="AJG_Vol.109.No.9 page 67" href="http://viewer.zmags.com/publication/e98596ea?page=67"> 1324 THE RED SECTION </a> <a title="AJG_Vol.109.No.9 page 68" href="http://viewer.zmags.com/publication/e98596ea?page=68"> nature publishing group </a> <a title="AJG_Vol.109.No.9 page 69" href="http://viewer.zmags.com/publication/e98596ea?page=69"> 1326 THE RED SECTION </a> <a title="AJG_Vol.109.No.9 page 70" href="http://viewer.zmags.com/publication/e98596ea?page=70"> nature publishing group </a> <a title="AJG_Vol.109.No.9 page 71" href="http://viewer.zmags.com/publication/e98596ea?page=71"> 1328 PRACTICE GUIDELINES </a> <a title="AJG_Vol.109.No.9 page 72" href="http://viewer.zmags.com/publication/e98596ea?page=72"> Diagnosis and Management of FLL 1329 Table </a> <a title="AJG_Vol.109.No.9 page 73" href="http://viewer.zmags.com/publication/e98596ea?page=73"> 1330 Marrero et al. Table 1. Continued 19.</a> <a title="AJG_Vol.109.No.9 page 74" href="http://viewer.zmags.com/publication/e98596ea?page=74"> also be applied to the evaluation of FLLs as show</a> <a title="AJG_Vol.109.No.9 page 75" href="http://viewer.zmags.com/publication/e98596ea?page=75"> 1332 Marrero et al. It has been estimat</a> <a title="AJG_Vol.109.No.9 page 76" href="http://viewer.zmags.com/publication/e98596ea?page=76"> Diagnosis and Management of FLL 1333 Table </a> <a title="AJG_Vol.109.No.9 page 77" href="http://viewer.zmags.com/publication/e98596ea?page=77"> 1334 Marrero et al. (56,57). Along with O</a> <a title="AJG_Vol.109.No.9 page 78" href="http://viewer.zmags.com/publication/e98596ea?page=78"> Nonsurgical modalities such as embolization can b</a> <a title="AJG_Vol.109.No.9 page 79" href="http://viewer.zmags.com/publication/e98596ea?page=79"> 1336 Marrero et al. Table 3. Imaging chara</a> <a title="AJG_Vol.109.No.9 page 80" href="http://viewer.zmags.com/publication/e98596ea?page=80"> adenomas must be differentiated accurately as FNH</a> <a title="AJG_Vol.109.No.9 page 81" href="http://viewer.zmags.com/publication/e98596ea?page=81"> 1338 Marrero et al. Table 4. Imaging chara</a> <a title="AJG_Vol.109.No.9 page 82" href="http://viewer.zmags.com/publication/e98596ea?page=82"> make evidence-based recommendations with strong s</a> <a title="AJG_Vol.109.No.9 page 83" href="http://viewer.zmags.com/publication/e98596ea?page=83"> 1340 Marrero et al. Management of biliary</a> <a title="AJG_Vol.109.No.9 page 84" href="http://viewer.zmags.com/publication/e98596ea?page=84"> symptomatic patients with hepatic failure and/or </a> <a title="AJG_Vol.109.No.9 page 85" href="http://viewer.zmags.com/publication/e98596ea?page=85"> 1342 Marrero et al. Approach to FLLs Ri</a> <a title="AJG_Vol.109.No.9 page 86" href="http://viewer.zmags.com/publication/e98596ea?page=86"> and management of liver masses based on the knowl</a> <a title="AJG_Vol.109.No.9 page 87" href="http://viewer.zmags.com/publication/e98596ea?page=87"> 1344 Marrero et al. 42. Llovet JM, Ricci S</a> <a title="AJG_Vol.109.No.9 page 88" href="http://viewer.zmags.com/publication/e98596ea?page=88"> 100. Kasabach HH, Merritt KK. Capillary hemangiom</a> <a title="AJG_Vol.109.No.9 page 89" href="http://viewer.zmags.com/publication/e98596ea?page=89"> 1346 Marrero et al. 157. Tocchi A, Mazzoni</a> <a title="AJG_Vol.109.No.9 page 90" href="http://viewer.zmags.com/publication/e98596ea?page=90"> 211. Brunetti E, Kern P, Vuitton DA et al. Expert</a> <a title="AJG_Vol.109.No.9 page 91" href="http://viewer.zmags.com/publication/e98596ea?page=91"> 1348 PRACTICE GUIDELINES </a> <a title="AJG_Vol.109.No.9 page 92" href="http://viewer.zmags.com/publication/e98596ea?page=92"> nature publishing group </a> <a title="AJG_Vol.109.No.9 page 93" href="http://viewer.zmags.com/publication/e98596ea?page=93"> 1350 CLINICAL AND SYSTEMATIC REVIEWS </a> <a title="AJG_Vol.109.No.9 page 94" href="http://viewer.zmags.com/publication/e98596ea?page=94"> consume > 50% more health-care resources than mat</a> <a title="AJG_Vol.109.No.9 page 95" href="http://viewer.zmags.com/publication/e98596ea?page=95"> 1352 Ford et al. REVIEW Box 2. Data extract</a> <a title="AJG_Vol.109.No.9 page 96" href="http://viewer.zmags.com/publication/e98596ea?page=96"> Studies identified in literature search</a> <a title="AJG_Vol.109.No.9 page 97" href="http://viewer.zmags.com/publication/e98596ea?page=97"> 1354 Ford et al. Table Diagnostic Criteri</a> <a title="AJG_Vol.109.No.9 page 98" href="http://viewer.zmags.com/publication/e98596ea?page=98"> Antidepressants and Psychological Therapies in IB</a> <a title="AJG_Vol.109.No.9 page 99" href="http://viewer.zmags.com/publication/e98596ea?page=99"> 1356 Ford et al. </a> <a title="AJG_Vol.109.No.9 page 100" href="http://viewer.zmags.com/publication/e98596ea?page=100"> Antidepressants and Psychological Therapies in IB</a> <a title="AJG_Vol.109.No.9 page 101" href="http://viewer.zmags.com/publication/e98596ea?page=101"> 1358 Ford et al. Criteria used to define </a> <a title="AJG_Vol.109.No.9 page 102" href="http://viewer.zmags.com/publication/e98596ea?page=102"> Antidepressants and Psychological Therapies in IB</a> <a title="AJG_Vol.109.No.9 page 103" href="http://viewer.zmags.com/publication/e98596ea?page=103"> 1360 Ford et al. Criteria used to define </a> <a title="AJG_Vol.109.No.9 page 104" href="http://viewer.zmags.com/publication/e98596ea?page=104"> Psychol</a> <a title="AJG_Vol.109.No.9 page 105" href="http://viewer.zmags.com/publication/e98596ea?page=105"> 1362 Ford et al. REVIEW multicomponent psyc</a> <a title="AJG_Vol.109.No.9 page 106" href="http://viewer.zmags.com/publication/e98596ea?page=106"> study methodology and design. Finally, we extract</a> <a title="AJG_Vol.109.No.9 page 107" href="http://viewer.zmags.com/publication/e98596ea?page=107"> 1364 Ford et al. Financial support: This </a> <a title="AJG_Vol.109.No.9 page 108" href="http://viewer.zmags.com/publication/e98596ea?page=108"> 50. Kennedy T, Jones R, Darnley S et al. Cognitiv</a> <a title="AJG_Vol.109.No.9 page 109" href="http://viewer.zmags.com/publication/e98596ea?page=109"> 1366 CLINICAL AND SYSTEMATIC REVIEWS </a> <a title="AJG_Vol.109.No.9 page 110" href="http://viewer.zmags.com/publication/e98596ea?page=110"> nature publishing group </a> <a title="AJG_Vol.109.No.9 page 111" href="http://viewer.zmags.com/publication/e98596ea?page=111"> 1368 Moayyedi et al. REVIEW Box 1. Eligibil</a> <a title="AJG_Vol.109.No.9 page 112" href="http://viewer.zmags.com/publication/e98596ea?page=112"> Data synthesis and statistical analysis Global IB</a> <a title="AJG_Vol.109.No.9 page 113" href="http://viewer.zmags.com/publication/e98596ea?page=113"> 1370 Moayyedi et al. REVIEW Table 1. Charac</a> <a title="AJG_Vol.109.No.9 page 114" href="http://viewer.zmags.com/publication/e98596ea?page=114"> Fiber Supplementation in IBS 1371 Table 1. </a> <a title="AJG_Vol.109.No.9 page 115" href="http://viewer.zmags.com/publication/e98596ea?page=115"> 1372 Moayyedi et al. REVIEW Table 2. Subgro</a> <a title="AJG_Vol.109.No.9 page 116" href="http://viewer.zmags.com/publication/e98596ea?page=116"> same data that the Cochrane review identified (26</a> <a title="AJG_Vol.109.No.9 page 117" href="http://viewer.zmags.com/publication/e98596ea?page=117"> 1374 Moayyedi et al. REVIEW 4. Ford AC, Ta</a> <a title="AJG_Vol.109.No.9 page 118" href="http://viewer.zmags.com/publication/e98596ea?page=118"> nature publishing group </a> <a title="AJG_Vol.109.No.9 page 119" href="http://viewer.zmags.com/publication/e98596ea?page=119"> 1376 Singh et al. REVIEW observed that 3.4%</a> <a title="AJG_Vol.109.No.9 page 120" href="http://viewer.zmags.com/publication/e98596ea?page=120"> in individual studies; (iv) outcomes—stage (I/II </a> <a title="AJG_Vol.109.No.9 page 121" href="http://viewer.zmags.com/publication/e98596ea?page=121"> 1378 Singh et al. Indentification </a> <a title="AJG_Vol.109.No.9 page 122" href="http://viewer.zmags.com/publication/e98596ea?page=122"> Epidemiology of Interval Colorectal Cancers 13</a> <a title="AJG_Vol.109.No.9 page 123" href="http://viewer.zmags.com/publication/e98596ea?page=123"> 1380 Singh et al. Risk factors for inter</a> <a title="AJG_Vol.109.No.9 page 124" href="http://viewer.zmags.com/publication/e98596ea?page=124"> Epidemiology of Interval Colorectal Cancers 13</a> <a title="AJG_Vol.109.No.9 page 125" href="http://viewer.zmags.com/publication/e98596ea?page=125"> 1382 Singh et al. REVIEW Table 2. Subgroup </a> <a title="AJG_Vol.109.No.9 page 126" href="http://viewer.zmags.com/publication/e98596ea?page=126"> Epidemiology of Interval Colorectal Cancers 13</a> <a title="AJG_Vol.109.No.9 page 127" href="http://viewer.zmags.com/publication/e98596ea?page=127"> 1384 Singh et al. Endoscopist's specialt</a> <a title="AJG_Vol.109.No.9 page 128" href="http://viewer.zmags.com/publication/e98596ea?page=128"> Epidemiology of Interval Colorectal Cancers 13</a> <a title="AJG_Vol.109.No.9 page 129" href="http://viewer.zmags.com/publication/e98596ea?page=129"> 1386 Singh et al. REVIEW Outcomes of interv</a> <a title="AJG_Vol.109.No.9 page 130" href="http://viewer.zmags.com/publication/e98596ea?page=130"> higher risks of incomplete colonoscopy and missed</a> <a title="AJG_Vol.109.No.9 page 131" href="http://viewer.zmags.com/publication/e98596ea?page=131"> 1388 Singh et al. on molecular phenotypin</a> <a title="AJG_Vol.109.No.9 page 132" href="http://viewer.zmags.com/publication/e98596ea?page=132"> 12. Singh H, Nugent Z, Demers AA et al. Rate and </a> <a title="AJG_Vol.109.No.9 page 133" href="http://viewer.zmags.com/publication/e98596ea?page=133"> 1390 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109.No.9 page 134" href="http://viewer.zmags.com/publication/e98596ea?page=134"> success of colonoscopy in these patients (8). The</a> <a title="AJG_Vol.109.No.9 page 135" href="http://viewer.zmags.com/publication/e98596ea?page=135"> 1392 Hsieh et al. ENDOSCOPY as needed (4–6)</a> <a title="AJG_Vol.109.No.9 page 136" href="http://viewer.zmags.com/publication/e98596ea?page=136"> Air Insufflation vs. Water Immersion and Exchange</a> <a title="AJG_Vol.109.No.9 page 137" href="http://viewer.zmags.com/publication/e98596ea?page=137"> 1394 Hsieh et al. ENDOSCOPY Table 2. Outcom</a> <a title="AJG_Vol.109.No.9 page 138" href="http://viewer.zmags.com/publication/e98596ea?page=138"> Air Insufflation vs. Water Immersion and Exchange</a> <a title="AJG_Vol.109.No.9 page 139" href="http://viewer.zmags.com/publication/e98596ea?page=139"> 1396 Hsieh et al. ENDOSCOPY Table 4. Multip</a> <a title="AJG_Vol.109.No.9 page 140" href="http://viewer.zmags.com/publication/e98596ea?page=140"> Air Insufflation vs. Water Immersion and Exchange</a> <a title="AJG_Vol.109.No.9 page 141" href="http://viewer.zmags.com/publication/e98596ea?page=141"> 1398 Hsieh et al. ENDOSCOPY not the WI grou</a> <a title="AJG_Vol.109.No.9 page 142" href="http://viewer.zmags.com/publication/e98596ea?page=142"> Study Highlights WHAT IS CURRENT KNOWLEDGE 3Wate</a> <a title="AJG_Vol.109.No.9 page 143" href="http://viewer.zmags.com/publication/e98596ea?page=143"> 1400 Hsieh et al. ENDOSCOPY 39. Manes G, Am</a> <a title="AJG_Vol.109.No.9 page 144" href="http://viewer.zmags.com/publication/e98596ea?page=144"> nature publishing group </a> <a title="AJG_Vol.109.No.9 page 145" href="http://viewer.zmags.com/publication/e98596ea?page=145"> 1402 Rex ENDOSCOPY There are several pro</a> <a title="AJG_Vol.109.No.9 page 146" href="http://viewer.zmags.com/publication/e98596ea?page=146"> 9. Hsieh Y-H, Koo M, Leung FW. A patient-blinded</a> <a title="AJG_Vol.109.No.9 page 147" href="http://viewer.zmags.com/publication/e98596ea?page=147"> 1404 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109.No.9 page 148" href="http://viewer.zmags.com/publication/e98596ea?page=148"> inexpensive diagnostic markers. Moreover, if an u</a> <a title="AJG_Vol.109.No.9 page 149" href="http://viewer.zmags.com/publication/e98596ea?page=149"> 1406 Meffert et al. LIVER specific protocol</a> <a title="AJG_Vol.109.No.9 page 150" href="http://viewer.zmags.com/publication/e98596ea?page=150"> On Diagnostic Scores for Hepatic Steatosis 140</a> <a title="AJG_Vol.109.No.9 page 151" href="http://viewer.zmags.com/publication/e98596ea?page=151"> 1408 Meffert et al. a 1.0 0.8 LIVER O</a> <a title="AJG_Vol.109.No.9 page 152" href="http://viewer.zmags.com/publication/e98596ea?page=152"> Table 3. Regression coefficients (β) for the diagn</a> <a title="AJG_Vol.109.No.9 page 153" href="http://viewer.zmags.com/publication/e98596ea?page=153"> 1410 Meffert et al. More studies using li</a> <a title="AJG_Vol.109.No.9 page 154" href="http://viewer.zmags.com/publication/e98596ea?page=154"> On Diagnostic Scores for Hepatic Steatosis 141</a> <a title="AJG_Vol.109.No.9 page 155" href="http://viewer.zmags.com/publication/e98596ea?page=155"> 1412 Meffert et al. LIVER Table A1. Continu</a> <a title="AJG_Vol.109.No.9 page 156" href="http://viewer.zmags.com/publication/e98596ea?page=156"> On Diagnostic Scores for Hepatic Steatosis 141</a> <a title="AJG_Vol.109.No.9 page 157" href="http://viewer.zmags.com/publication/e98596ea?page=157"> 1414 Meffert et al. LIVER Table A1. Continu</a> <a title="AJG_Vol.109.No.9 page 158" href="http://viewer.zmags.com/publication/e98596ea?page=158"> nature publishing group </a> <a title="AJG_Vol.109.No.9 page 159" href="http://viewer.zmags.com/publication/e98596ea?page=159"> 1416 Cumberledge and Angulo LIVER Although </a> <a title="AJG_Vol.109.No.9 page 160" href="http://viewer.zmags.com/publication/e98596ea?page=160"> nature publishing group </a> <a title="AJG_Vol.109.No.9 page 161" href="http://viewer.zmags.com/publication/e98596ea?page=161"> 1418 Singh et al. Enrollment Assessed for</a> <a title="AJG_Vol.109.No.9 page 162" href="http://viewer.zmags.com/publication/e98596ea?page=162"> Venous blood was collected at baseline and on day</a> <a title="AJG_Vol.109.No.9 page 163" href="http://viewer.zmags.com/publication/e98596ea?page=163"> 1420 Singh et al. LIVER Table 1. Baseline c</a> <a title="AJG_Vol.109.No.9 page 164" href="http://viewer.zmags.com/publication/e98596ea?page=164"> G-CSF in Alcoholic Hepatitis 1421 Table 2. </a> <a title="AJG_Vol.109.No.9 page 165" href="http://viewer.zmags.com/publication/e98596ea?page=165"> 1422 Singh et al. 1.0 0.8 0.6 LIV</a> <a title="AJG_Vol.109.No.9 page 166" href="http://viewer.zmags.com/publication/e98596ea?page=166"> Study Highlights WHAT IS CURRENT KNOWLEDGE 3Seve</a> <a title="AJG_Vol.109.No.9 page 167" href="http://viewer.zmags.com/publication/e98596ea?page=167"> 1424 EDITORIAL </a> <a title="AJG_Vol.109.No.9 page 168" href="http://viewer.zmags.com/publication/e98596ea?page=168"> Glucocorticoid Bacterial produc</a> <a title="AJG_Vol.109.No.9 page 169" href="http://viewer.zmags.com/publication/e98596ea?page=169"> 1426 Moreau and Rautou LIVER patients were </a> <a title="AJG_Vol.109.No.9 page 170" href="http://viewer.zmags.com/publication/e98596ea?page=170"> nature publishing group </a> <a title="AJG_Vol.109.No.9 page 171" href="http://viewer.zmags.com/publication/e98596ea?page=171"> 1428 El-Serag et al. LIVER AAs compared wit</a> <a title="AJG_Vol.109.No.9 page 172" href="http://viewer.zmags.com/publication/e98596ea?page=172"> basis of diagnostic codes for hepatic decompensat</a> <a title="AJG_Vol.109.No.9 page 173" href="http://viewer.zmags.com/publication/e98596ea?page=173"> 1430 El-Serag et al. LIVER Table 1. Demogra</a> <a title="AJG_Vol.109.No.9 page 174" href="http://viewer.zmags.com/publication/e98596ea?page=174"> Cumulative incidence rate 50% 45% 40% 35% 30% 25</a> <a title="AJG_Vol.109.No.9 page 175" href="http://viewer.zmags.com/publication/e98596ea?page=175"> 1432 El-Serag et al. LIVER Table 2. Associa</a> <a title="AJG_Vol.109.No.9 page 176" href="http://viewer.zmags.com/publication/e98596ea?page=176"> Effect of race on cirrhosis and HCC risk 1433 </a> <a title="AJG_Vol.109.No.9 page 177" href="http://viewer.zmags.com/publication/e98596ea?page=177"> 1434 El-Serag et al. LIVER Table 4. Racial </a> <a title="AJG_Vol.109.No.9 page 178" href="http://viewer.zmags.com/publication/e98596ea?page=178"> REFERENCES 1. Crosse K, Umeadi OG, Anania FA et </a> <a title="AJG_Vol.109.No.9 page 179" href="http://viewer.zmags.com/publication/e98596ea?page=179"> 1436 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109.No.9 page 180" href="http://viewer.zmags.com/publication/e98596ea?page=180"> Although early diagnosis by paracentesis is cr</a> <a title="AJG_Vol.109.No.9 page 181" href="http://viewer.zmags.com/publication/e98596ea?page=181"> 1438 Kim et al. LIVER Table 1. Baseline cha</a> <a title="AJG_Vol.109.No.9 page 182" href="http://viewer.zmags.com/publication/e98596ea?page=182"> Table 2. Clinical outcomes EP, N=141 DP, N</a> <a title="AJG_Vol.109.No.9 page 183" href="http://viewer.zmags.com/publication/e98596ea?page=183"> 1440 Kim et al. LIVER Table 3. Univariate a</a> <a title="AJG_Vol.109.No.9 page 184" href="http://viewer.zmags.com/publication/e98596ea?page=184"> Patients with cirrhosis frequently develop lif</a> <a title="AJG_Vol.109.No.9 page 185" href="http://viewer.zmags.com/publication/e98596ea?page=185"> 1442 Kim et al. LIVER data collection. B. R</a> <a title="AJG_Vol.109.No.9 page 186" href="http://viewer.zmags.com/publication/e98596ea?page=186"> nature publishing group </a> <a title="AJG_Vol.109.No.9 page 187" href="http://viewer.zmags.com/publication/e98596ea?page=187"> 1444 Amiot et al. INFLAMMATORY BOWEL DISEASE</a> <a title="AJG_Vol.109.No.9 page 188" href="http://viewer.zmags.com/publication/e98596ea?page=188"> Outcome of CD-Related Enterocutaneous Fistula Tre</a> <a title="AJG_Vol.109.No.9 page 189" href="http://viewer.zmags.com/publication/e98596ea?page=189"> 1446 Amiot et al. INFLAMMATORY BOWEL DISEASE</a> <a title="AJG_Vol.109.No.9 page 190" href="http://viewer.zmags.com/publication/e98596ea?page=190"> Outcome of CD-Related Enterocutaneous Fistula Tre</a> <a title="AJG_Vol.109.No.9 page 191" href="http://viewer.zmags.com/publication/e98596ea?page=191"> 0123 Time since the sta</a> <a title="AJG_Vol.109.No.9 page 192" href="http://viewer.zmags.com/publication/e98596ea?page=192"> Outcome of CD-Related Enterocutaneous Fistula Tre</a> <a title="AJG_Vol.109.No.9 page 193" href="http://viewer.zmags.com/publication/e98596ea?page=193"> 1450 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109.No.9 page 194" href="http://viewer.zmags.com/publication/e98596ea?page=194"> majority of patients of all IBS subtypes, and the</a> <a title="AJG_Vol.109.No.9 page 195" href="http://viewer.zmags.com/publication/e98596ea?page=195"> 1452 Palsson et al. FUNCTIONAL GI DISORDERS </a> <a title="AJG_Vol.109.No.9 page 196" href="http://viewer.zmags.com/publication/e98596ea?page=196"> interval for the averaged cross-correlation coeff</a> <a title="AJG_Vol.109.No.9 page 197" href="http://viewer.zmags.com/publication/e98596ea?page=197"> 1454 Palsson et al. FUNCTIONAL GI DISORDERS </a> <a title="AJG_Vol.109.No.9 page 198" href="http://viewer.zmags.com/publication/e98596ea?page=198"> Table 4a. Mean % of total diarrhea BMs in the sub</a> <a title="AJG_Vol.109.No.9 page 199" href="http://viewer.zmags.com/publication/e98596ea?page=199"> 1456 Palsson et al. Abdominal pain inten</a> <a title="AJG_Vol.109.No.9 page 200" href="http://viewer.zmags.com/publication/e98596ea?page=200"> 100 90 80 70 60 50 40 30 20 10 0 </a> <a title="AJG_Vol.109.No.9 page 201" href="http://viewer.zmags.com/publication/e98596ea?page=201"> 1458 Palsson et al. FUNCTIONAL GI DISORDERS </a> <a title="AJG_Vol.109.No.9 page 202" href="http://viewer.zmags.com/publication/e98596ea?page=202"> limitations including missed days of reporting (1</a> <a title="AJG_Vol.109.No.9 page 203" href="http://viewer.zmags.com/publication/e98596ea?page=203"> 1460 Palsson et al. FUNCTIONAL GI DISORDERS </a> <a title="AJG_Vol.109.No.9 page 204" href="http://viewer.zmags.com/publication/e98596ea?page=204"> nature publishing group </a> <a title="AJG_Vol.109.No.9 page 205" href="http://viewer.zmags.com/publication/e98596ea?page=205"> 1462 Macaigne et al. FUNCTIONAL GI DISORDERS</a> <a title="AJG_Vol.109.No.9 page 206" href="http://viewer.zmags.com/publication/e98596ea?page=206"> MC or FBD-D: A French Prospective Multicenter Stu</a> <a title="AJG_Vol.109.No.9 page 207" href="http://viewer.zmags.com/publication/e98596ea?page=207"> 1464 Macaigne et al. FUNCTIONAL GI DISORDERS</a> <a title="AJG_Vol.109.No.9 page 208" href="http://viewer.zmags.com/publication/e98596ea?page=208"> MC or FBD-D: A French Prospective Multicenter Stu</a> <a title="AJG_Vol.109.No.9 page 209" href="http://viewer.zmags.com/publication/e98596ea?page=209"> 1466 Macaigne et al. FUNCTIONAL GI DISORDERS</a> <a title="AJG_Vol.109.No.9 page 210" href="http://viewer.zmags.com/publication/e98596ea?page=210"> 30 Microscopic colitis 25 20 Functional bowel</a> <a title="AJG_Vol.109.No.9 page 211" href="http://viewer.zmags.com/publication/e98596ea?page=211"> 1468 Macaigne et al. FUNCTIONAL GI DISORDERS</a> <a title="AJG_Vol.109.No.9 page 212" href="http://viewer.zmags.com/publication/e98596ea?page=212"> during the 6 months preceding the onset of diarrh</a> <a title="AJG_Vol.109.No.9 page 213" href="http://viewer.zmags.com/publication/e98596ea?page=213"> 1470 Macaigne et al. FUNCTIONAL GI DISORDERS</a> <a title="AJG_Vol.109.No.9 page 214" href="http://viewer.zmags.com/publication/e98596ea?page=214"> nature publishing group </a> <a title="AJG_Vol.109.No.9 page 215" href="http://viewer.zmags.com/publication/e98596ea?page=215"> 1472 Ilus et al. COLON/SMALL BOWEL Complian</a> <a title="AJG_Vol.109.No.9 page 216" href="http://viewer.zmags.com/publication/e98596ea?page=216"> Malignancies in Celiac Disease 1473 Table 2</a> <a title="AJG_Vol.109.No.9 page 217" href="http://viewer.zmags.com/publication/e98596ea?page=217"> 1474 Ilus et al. All cases 0–2 Years 2–5 Yea</a> <a title="AJG_Vol.109.No.9 page 218" href="http://viewer.zmags.com/publication/e98596ea?page=218"> Malignancies in Celiac Disease Small intestine c</a> <a title="AJG_Vol.109.No.9 page 219" href="http://viewer.zmags.com/publication/e98596ea?page=219"> 1476 Ilus et al. COLON/SMALL BOWEL owing to</a> <a title="AJG_Vol.109.No.9 page 220" href="http://viewer.zmags.com/publication/e98596ea?page=220"> Study Highlights WHAT IS CURRENT KNOWLEDGE 3Lite</a> <a title="AJG_Vol.109.No.9 page 221" href="http://viewer.zmags.com/publication/e98596ea?page=221"> 1478 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109.No.9 page 222" href="http://viewer.zmags.com/publication/e98596ea?page=222"> intraepithelial lymphocytosis, crypt hyperplasia,</a> <a title="AJG_Vol.109.No.9 page 223" href="http://viewer.zmags.com/publication/e98596ea?page=223"> 1480 Bannister et al. COLON/SMALL BOWEL Fig</a> <a title="AJG_Vol.109.No.9 page 224" href="http://viewer.zmags.com/publication/e98596ea?page=224"> Table 1. Mucosal assessment according to serologi</a> <a title="AJG_Vol.109.No.9 page 225" href="http://viewer.zmags.com/publication/e98596ea?page=225"> 1482 Bannister et al. COLON/SMALL BOWEL GFD</a> <a title="AJG_Vol.109.No.9 page 226" href="http://viewer.zmags.com/publication/e98596ea?page=226"> CONFLICT OF INTEREST Guarantor of the article: Wi</a> <a title="AJG_Vol.109.No.9 page 227" href="http://viewer.zmags.com/publication/e98596ea?page=227"> 1484 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109.No.9 page 228" href="http://viewer.zmags.com/publication/e98596ea?page=228"> Pancreatic Cancer-Associated Diabetes Mellitus </a> <a title="AJG_Vol.109.No.9 page 229" href="http://viewer.zmags.com/publication/e98596ea?page=229"> 1486 Hart et al. PANCREAS AND BILIARY TRACT </a> <a title="AJG_Vol.109.No.9 page 230" href="http://viewer.zmags.com/publication/e98596ea?page=230"> Table 1. Tumor characteristics for 488 pancreatic</a> <a title="AJG_Vol.109.No.9 page 231" href="http://viewer.zmags.com/publication/e98596ea?page=231"> 1488 Hart et al. BILIARY TRACT PANCREAS AND </a> <a title="AJG_Vol.109.No.9 page 232" href="http://viewer.zmags.com/publication/e98596ea?page=232"> Pancreatic Cancer-Associated Diabetes Mellitus </a> <a title="AJG_Vol.109.No.9 page 233" href="http://viewer.zmags.com/publication/e98596ea?page=233"> 1490 Hart et al. BILIARY TRACT PANCREAS AND </a> <a title="AJG_Vol.109.No.9 page 234" href="http://viewer.zmags.com/publication/e98596ea?page=234"> Table 5. Factors independently associated with in</a> <a title="AJG_Vol.109.No.9 page 235" href="http://viewer.zmags.com/publication/e98596ea?page=235"> 1492 Hart et al. William R. Bamlet, Kari </a> <a title="AJG_Vol.109.No.9 page 236" href="http://viewer.zmags.com/publication/e98596ea?page=236"> nature publishing group </a> <a title="AJG_Vol.109.No.9 page 237" href="http://viewer.zmags.com/publication/e98596ea?page=237"> 1494 Letters to the Editor Study </a> <a title="AJG_Vol.109.No.9 page 238" href="http://viewer.zmags.com/publication/e98596ea?page=238"> We agree with them that conclusions about t</a> <a title="AJG_Vol.109.No.9 page 239" href="http://viewer.zmags.com/publication/e98596ea?page=239"> 1496 Letters to the Editor interpret the e</a> <a title="AJG_Vol.109.No.9 page 240" href="http://viewer.zmags.com/publication/e98596ea?page=240"> 48 cases/72 months), and enrollment crite- ria fo</a> <a title="AJG_Vol.109.No.9 page 241" href="http://viewer.zmags.com/publication/e98596ea?page=241"> 1498 Letters to the Editor Nevertheless, w</a> <a title="AJG_Vol.109.No.9 page 242" href="http://viewer.zmags.com/publication/e98596ea?page=242"> Letters to the Editor 1499 Table 1. Studies</a> <a title="AJG_Vol.109.No.9 page 243" href="http://viewer.zmags.com/publication/e98596ea?page=243"> 1500 Letters to the Editor response to glu</a> <a title="AJG_Vol.109.No.9 page 244" href="http://viewer.zmags.com/publication/e98596ea?page=244"> the primary care setting. Am J Gastroenter</a> <a title="AJG_Vol.109.No.9 page 245" href="http://viewer.zmags.com/publication/e98596ea?page=245"> 1502 Letters to the Editor biopsy of her r</a> <a title="AJG_Vol.109.No.9 page 246" href="http://viewer.zmags.com/publication/e98596ea?page=246"> nature publishing group </a> <a title="AJG_Vol.109.No.9 page 247" href="http://viewer.zmags.com/publication/e98596ea?page=247"> 1504 ERRATA, CORRIGENDA AND RETRACTIONS </a> <a title="AJG_Vol.109.No.9 page 248" href="http://viewer.zmags.com/publication/e98596ea?page=248"> CLASSIFIEDS DEDICATED TO THE COMMUNITY Competi</a> <a title="AJG_Vol.109.No.9 page 249" href="http://viewer.zmags.com/publication/e98596ea?page=249"> BC/BE Gastroenterologist Gastroenterologists </a> <a title="AJG_Vol.109.No.9 page 250" href="http://viewer.zmags.com/publication/e98596ea?page=250"> BC/BE Gastroenterologist Thriving GI practice, w</a> <a title="AJG_Vol.109.No.9 page 251" href="http://viewer.zmags.com/publication/e98596ea?page=251"> The American Journal of Gastroenterology </a> <a title="AJG_Vol.109.No.9 page 252" href="http://viewer.zmags.com/publication/e98596ea?page=252"> </a> <a title="AJG_Vol.109.No.9 page 253" href="http://viewer.zmags.com/publication/e98596ea?page=253"> </a>